Partnering to optimize commercial value for our robust pipeline of oncology and orphan products.

Business Development

Partnering is an important value driver allowing us to maximize the commercial potential of our extensive drug development pipeline while focusing our efforts on selected drug candidates. We are actively seeking partnerships for our biodefense program both in the U.S. and globally in selected territories and are in parallel pursuing partnering opportunities for our preclinical and clinical stage oncology programs.

Please contact with any partnering inquiries.

You are now leaving this website. If you would like to continue, click Continue.